Vi dækker
ASH | American Society of Hematology Meeting & Exposition
ASH 2024
Dansk Aften ASH 2024: Nye fremskridt i behandling af CLL
/ Emelie Hamotal Curovic Rotbain
LBA-2: A New Cause of Hereditary and Acquired Erythrocytosis
/ Betty Gardie / Francois Girodon
ASH 2024: AML-forskning tar nye steg med CPX-behandling og meninhemmere
/ Bjørn Tore Gjertsen
ASH 2024: Siste behandlinger og forskningsfremskritt innen hematologi
/ Tobias S. Slørdahl
AI Will Play a Significant Role in All Aspects of Hematology in the Future
/ Andrew Srisuwananukorn
ASH 2023
ASH 2022
Superior efficacy of Iptacopan in PNH patients
/ Régis Peffault De Latour
CLL – Update fra ASH 2022
/ Carsten Utoft Niemann
New potential key pathway in patients with ALL
/ Signe Modvig
ASH 2021
CAR-T-terapi til behandling av storcellet B-cellelymfom
/ Alexander Fosså
Relapse vaccine is a promising treatment for patients with AML
/ Bjørn Tore Gjertsen